Close menu

SURE

Sunderland Repository records the research produced by the University of Sunderland including practice-based research and theses.

Identification of novel small-molecule inhibitors of α-methylacyl-CoA racemase (AMACR; P504S) and structure activity relationships

Petrova, Yoana, D., Wadda, Katty, Nathubhai, Amit, Yevglevskis, Maksims, Mitchell, Paul, J., James, Tony, D., Threadgill, Michael, D., Woodman, Timothy, J. and Lloyd, Matthew, D. (2019) Identification of novel small-molecule inhibitors of α-methylacyl-CoA racemase (AMACR; P504S) and structure activity relationships. Bioorganic Chemistry, 92 (103264). pp. 1-6. ISSN 0045-2068

Item Type: Article

Abstract

α-Methylacyl-CoA racemase (AMACR; P504S; EC 5.1.99.4) catalyses epimerization of 2-methylacyl-CoAs and is
important for the degradation of branched-chain fatty acids and the pharmacological activation of ibuprofen and
related drugs. It is also a novel drug target for prostate and other cancers. However, development of AMACR as a drug target has been hampered by the difficulties in assaying enzyme activity. Consequently, reported inhibitors have been rationally designed acyl-CoA esters, which are delivered as their carboxylate prodrugs. The novel colorimetric assay for AMACR based on the elimination of 2,4-dinitrophenolate was developed for highthroughput screening and 20,387 ‘drug-like compounds’ were screened, with a throughput of 768 compounds
assayed per day. Pyrazoloquinolines and pyrazolopyrimidines were identified as novel scaffolds and investigated as AMACR inhibitors. The most potent inhibitors have IC50 values of ~2 μM. The pyrazoloquinoline inhibitor 10a displayed uncompetitive inhibition, whilst 10j displayed mixed competitive inhibition. The pyrazolopyrimidine inhibitor 11k displayed uncompetitive inhibition. This is the first report of the identification of specific drug-like small-molecule AMACR inhibitors by high-throughput screening. Pyrazoloquinolines and pyrazolopyrimidines may also be useful as inhibitors of other CoA-utilizing enzymes.

[img]
Preview
PDF
Nathubhai. Amit AAM.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (357kB) | Preview

More Information

Related URLs:
Depositing User: Amit Nathubhai

Identifiers

Item ID: 11123
Identification Number: https://doi.org/10.1016/j.bioorg.2019.103264
ISSN: 0045-2068
URI: http://sure.sunderland.ac.uk/id/eprint/11123
Official URL: https://doi.org/10.1016/j.bioorg.2019.103264

Users with ORCIDS

ORCID for Amit Nathubhai: ORCID iD orcid.org/0000-0003-3686-2799

Catalogue record

Date Deposited: 19 Sep 2019 10:08
Last Modified: 30 Sep 2020 10:47

Contributors

Author: Amit Nathubhai ORCID iD
Author: Yoana, D. Petrova
Author: Katty Wadda
Author: Maksims Yevglevskis
Author: Paul, J. Mitchell
Author: Tony, D. James
Author: Michael, D. Threadgill
Author: Timothy, J. Woodman
Author: Matthew, D. Lloyd

University Divisions

Faculty of Health Sciences and Wellbeing
Faculty of Health Sciences and Wellbeing > School of Pharmacy and Pharmaceutical Sciences

Subjects

Sciences > Chemistry

Actions (login required)

View Item (Repository Staff Only) View Item (Repository Staff Only)